Moberg Pharma AB (publ) - Asset Resilience Ratio

Latest as of September 2025: 5.24%

Moberg Pharma AB (publ) (MOB) has an Asset Resilience Ratio of 5.24% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Moberg Pharma AB (publ) carry for a breakdown of total debt and financial obligations.

Liquid Assets

Skr36.31 Million

≈ $3.91 Million USD Cash + Short-term Investments

Total Assets

Skr693.66 Million

≈ $74.65 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Moberg Pharma AB (publ)'s Asset Resilience Ratio has changed over time. See MOB net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Moberg Pharma AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Moberg Pharma AB (publ) (MOB) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr36.31 Million	5.24%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr36.31 Million	5.24%

Asset Resilience Insights

Limited Liquidity: Moberg Pharma AB (publ) maintains only 5.24% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Moberg Pharma AB (publ) Industry Peers by Asset Resilience Ratio

Compare Moberg Pharma AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Moberg Pharma AB (publ) (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Moberg Pharma AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.94%	Skr34.91 Million ≈ $3.76 Million	Skr706.09 Million ≈ $75.99 Million	-2.81pp
2023-12-31	7.76%	Skr49.25 Million ≈ $5.30 Million	Skr634.73 Million ≈ $68.31 Million	-0.80pp
2022-12-31	8.55%	Skr48.28 Million ≈ $5.20 Million	Skr564.42 Million ≈ $60.74 Million	+0.44pp
2021-12-31	8.12%	Skr36.60 Million ≈ $3.94 Million	Skr450.89 Million ≈ $48.52 Million	-15.13pp
2020-12-31	23.25%	Skr111.73 Million ≈ $12.02 Million	Skr480.58 Million ≈ $51.72 Million	-0.36pp
2019-12-31	23.61%	Skr30.84 Million ≈ $3.32 Million	Skr130.59 Million ≈ $14.05 Million	+22.79pp
2018-12-31	0.82%	Skr10.32 Million ≈ $1.11 Million	Skr1.25 Billion ≈ $134.69 Million	+0.51pp
2017-12-31	0.32%	Skr3.90 Million ≈ $419.44K	Skr1.22 Billion ≈ $131.64 Million	--

pp = percentage points

About Moberg Pharma AB (publ)

ST:MOB Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$58.17 Million

Skr540.51 Million SEK

Market Cap Rank

#21302 Global

#387 in Sweden

Share Price

Skr11.50

Change (1 day)

+3.98%

52-Week Range

Skr7.33 - Skr12.40

All Time High

Skr226.13